These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Clinical Outcome
14 results:

  • 1. Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab.
    Manneh Kopp RA; Sepúlveda-Sánchez JM; Ruano Y; Toldos O; Pérez Núñez A; Cantero D; Hilario A; Ramos A; de Velasco G; Sánchez-Gómez P; Hernández-Laín A
    Clin Transl Oncol; 2019 Oct; 21(10):1413-1423. PubMed ID: 30877636
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Spontaneous intracerebral hemorrhage as presentation of atypical central neurocytoma: the role of angiogenesis through the characterization of tumor endothelial cells.
    Marfia G; Pirola E; Navone SE; Beretta M; Guarnaccia L; Trombetta E; Franzini A; Rampini P; Campanella R
    Histol Histopathol; 2018 Jul; 33(7):665-672. PubMed ID: 29215136
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Autophagy-induced kdr/vegfr-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
    Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW
    Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours.
    Zurita AJ; Khajavi M; Wu HK; Tye L; Huang X; Kulke MH; Lenz HJ; Meropol NJ; Carley W; DePrimo SE; Lin E; Wang X; Harmon CS; Heymach JV
    Br J Cancer; 2015 Mar; 112(7):1199-205. PubMed ID: 25756398
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Correlation of somatic mutations and clinical outcome in melanoma patients treated with Carboplatin, Paclitaxel, and sorafenib.
    Wilson MA; Zhao F; Letrero R; D'Andrea K; Rimm DL; Kirkwood JM; Kluger HM; Lee SJ; Schuchter LM; Flaherty KT; Nathanson KL
    Clin Cancer Res; 2014 Jun; 20(12):3328-37. PubMed ID: 24714776
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma.
    Burford A; Little SE; Jury A; Popov S; Laxton R; Doey L; Al-Sarraj S; Jürgensmeier JM; Jones C
    PLoS One; 2013; 8(8):e71777. PubMed ID: 23990986
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Role of platelet derived growth factor receptor (PDGFR) over-expression and angiogenesis in ependymoma.
    Moreno L; Popov S; Jury A; Al Sarraj S; Jones C; Zacharoulis S
    J Neurooncol; 2013 Jan; 111(2):169-76. PubMed ID: 23135775
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Vandetanib: in medullary thyroid cancer.
    Frampton JE
    Drugs; 2012 Jul; 72(10):1423-36. PubMed ID: 22715896
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Phosphorylated pvegfr2/kdr receptor expression in uveal melanomas: relation with HIF2α and survival.
    Giatromanolaki A; Sivridis E; Bechrakis NE; Willerding G; St Charitoudis G; Foerster MH; Gatter KC; Harris AL; Koukourakis MI
    Clin Exp Metastasis; 2012 Jan; 29(1):11-7. PubMed ID: 21984395
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Neural stem cell tropism to glioma: critical role of tumor hypoxia.
    Zhao D; Najbauer J; Garcia E; Metz MZ; Gutova M; Glackin CA; Kim SU; Aboody KS
    Mol Cancer Res; 2008 Dec; 6(12):1819-29. PubMed ID: 19074827
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
    Brychtova S; Bezdekova M; Brychta T; Tichy M
    Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases.
    Lee L; Sharma S; Morgan B; Allegrini P; Schnell C; Brueggen J; Cozens R; Horsfield M; Guenther C; Steward WP; Drevs J; Lebwohl D; Wood J; McSheehy PM
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):761-71. PubMed ID: 16172907
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Angiogenesis and vascular growth factor receptor expression in malignant melanoma.
    Lin EY; Piepkorn M; Garcia R; Byrd D; Tsou R; Isik FF
    Plast Reconstr Surg; 1999 Nov; 104(6):1666-74. PubMed ID: 10541167
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Vascular endothelial growth factor expression in human neuroblastoma: up-regulation by hypoxia.
    Rössler J; Breit S; Havers W; Schweigerer L
    Int J Cancer; 1999 Mar; 81(1):113-7. PubMed ID: 10077161
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.